Literature DB >> 12563177

Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.

Bharti Mackness1, Paul Durrington, Andrew Povey, Stuart Thomson, Martin Dippnall, Mike Mackness, Ted Smith, Nicola Cherry.   

Abstract

OBJECTIVES: Human serum paraoxonase (PON1) hydrolyses organophosphate pesticides (OPs) entering the blood circulation and tissue fluid thus limiting toxicity. The PON1 coding region has two polymorphisms involving the amino acids at position 55 (Lt<--M) and 192 (Qt<--R), giving rise to isoenzymes which differ in their catalytic rate for the hydrolysis of OPs. We therefore hypothesized that individuals inheriting low activity isoforms of PON1 would be more liable to report symptoms of OP toxicity.
METHODS: We have therefore investigated the relationship between PON1 genetic polymorphisms and PON1 activity in farmers reporting chronic ill health which they attributed to OP exposure whilst sheep dipping (cases) and farmers who carried out similar activities, but remained well (controls). Diazoxon, paraoxon and phenylacetate were used as substrates for PON1. Diazoxon is the active metabolite of diazinon, the sheep dip most commonly used in the UK.
RESULTS: Cases were found to be more likely to have the R192 allele ( 0.01) and to have the L55 allele ( 0.05) than the controls. This combination of R and L genotypes was associated with lower PON1 activity towards diazoxon in both cases and controls. Farmers in the lowest quintile for the rate of serum diazoxon hydrolysis had a greater risk of being a case i.e. of reporting ill health (odds ratio 2.47 (95% CI 1.35-2.82)), than the other four quintiles of diazoxon hydrolysis. The rate of serum hydrolysis of paraoxon was greatest in cases and controls with the R/L haplotype (both 0.001).
CONCLUSIONS: The farmers reporting chronic ill health due to organophosphate exposure have a higher proportion of the PON1-192R polymorphism associated with lower rates of diazoxon hydrolysis and lower rates of diazoxon hydrolysis than the controls and that their ill health may be explained by a lower ability to detoxify diazoxon.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563177     DOI: 10.1097/00008571-200302000-00004

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  23 in total

Review 1.  Human PON1, a biomarker of risk of disease and exposure.

Authors:  C E Furlong; S M Suzuki; R C Stevens; J Marsillach; R J Richter; G P Jarvik; H Checkoway; A Samii; L G Costa; A Griffith; J W Roberts; D Yearout; C P Zabetian
Journal:  Chem Biol Interact       Date:  2010-03-23       Impact factor: 5.192

2.  The challenges of exposure assessment in health studies of Gulf War veterans.

Authors:  Deborah C Glass; Malcolm R Sim
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

Review 3.  Serum paraoxonase-1 (PON-1) genotype and exposure to organophosphorous insectides--is there a high-risk population?

Authors:  Andre R Matthews; Mark E Sutter; Danielle E Rentz
Journal:  J Med Toxicol       Date:  2011-09

4.  PON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifos.

Authors:  Corie A Ellison; Alice L Crane; Matthew R Bonner; James B Knaak; Richard W Browne; Pamela J Lein; James R Olson
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-10       Impact factor: 4.219

5.  The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Women's Heart and Health Study.

Authors:  Debbie A Lawlor; Ian N M Day; Tom R Gaunt; Lesley J Hinks; Nick Timpson; Shah Ebrahim; George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2007-01       Impact factor: 3.710

Review 6.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

7.  Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides.

Authors:  Sarah Jane Mackenzie Ross; Chris Ray Brewin; Helen Valerie Curran; Clement Eugene Furlong; Kelly Michelle Abraham-Smith; Virginia Harrison
Journal:  Neurotoxicol Teratol       Date:  2010-03-20       Impact factor: 3.763

Review 8.  Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Authors:  Lucio G Costa; Gennaro Giordano; Toby B Cole; Judit Marsillach; Clement E Furlong
Journal:  Toxicology       Date:  2012-07-31       Impact factor: 4.221

9.  The paraoxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or INCHIANTI studies.

Authors:  Neil E Rice; Stefania Bandinelli; Anna Maria Corsi; Luigi Ferrucci; Jack M Guralnik; Michelle A Miller; Meena Kumari; Anna Murray; Tim M Frayling; David Melzer
Journal:  Int J Epidemiol       Date:  2009-08-03       Impact factor: 7.196

10.  Serum cholinesterase inhibition in relation to paraoxonase-1 (PON1) status among organophosphate-exposed agricultural pesticide handlers.

Authors:  Jonathan N Hofmann; Matthew C Keifer; Clement E Furlong; Anneclaire J De Roos; Federico M Farin; Richard A Fenske; Gerald van Belle; Harvey Checkoway
Journal:  Environ Health Perspect       Date:  2009-06-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.